[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Repligen Corp (RGEN)

Repligen Corp (RGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,831,459
  • Shares Outstanding, K 56,408
  • Annual Sales, $ 738,260 K
  • Annual Income, $ 48,890 K
  • EBIT $ 65 M
  • EBITDA $ 160 M
  • 60-Month Beta 1.09
  • Price/Sales 8.18
  • Price/Cash Flow 33.25
  • Price/Book 3.04

Options Overview Details

View History
  • Implied Volatility 51.34% (+4.85%)
  • Historical Volatility 56.65%
  • IV Percentile 65%
  • IV Rank 52.96%
  • IV High 65.02% on 04/27/26
  • IV Low 35.94% on 08/14/25
  • Expected Move (DTE 34) 11.09 (10.73%)
  • Put/Call Vol Ratio 0.02
  • Today's Volume 1,809
  • Volume Avg (30-Day) 325
  • Put/Call OI Ratio 1.09
  • Today's Open Interest 8,150
  • Open Int (30-Day) 7,571
  • Expected Range 92.29 to 114.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.46
  • Number of Estimates 5
  • High Estimate $0.48
  • Low Estimate $0.44
  • Prior Year $0.37
  • Growth Rate Est. (year over year) +24.32%

Price Performance

See More
Period Period Low Period High Performance
1-Month
100.99 +2.37%
on 05/14/26
141.46 -26.92%
on 04/21/26
-27.65 (-21.10%)
since 04/14/26
3-Month
100.99 +2.37%
on 05/14/26
141.46 -26.92%
on 04/21/26
-33.06 (-24.23%)
since 02/13/26
52-Week
100.99 +2.37%
on 05/14/26
175.77 -41.18%
on 01/06/26
-24.66 (-19.26%)
since 05/14/25

Most Recent Stories

More News
1 Growth Stock with Explosive Upside and 2 Facing Headwinds

1 Growth Stock with Explosive Upside and 2 Facing Headwinds

PAR : 14.55 (+2.68%)
VEEV : 156.25 (+0.33%)
RGEN : 103.38 (-3.41%)
Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

Repligen, AdaptHealth, and IQVIA Stocks Trade Down, What You Need To Know

RGEN : 103.38 (-3.41%)
AHCO : 10.74 (-0.65%)
IQV : 170.68 (-0.99%)
5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call

5 Revealing Analyst Questions From Repligen’s Q1 Earnings Call

RGEN : 103.38 (-3.41%)
3 Small-Cap Stocks We Steer Clear Of

3 Small-Cap Stocks We Steer Clear Of

GFF : 85.91 (+3.67%)
RGEN : 103.38 (-3.41%)
HOMB : 25.85 (+0.35%)
Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

WALTHAM, Mass., May 07, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will participate in...

RGEN : 103.38 (-3.41%)
Repligen (RGEN) Shares Skyrocket, What You Need To Know

Repligen (RGEN) Shares Skyrocket, What You Need To Know

RGEN : 103.38 (-3.41%)
Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates

Repligen’s (NASDAQ:RGEN) Q1 CY2026 Sales Beat Estimates

RGEN : 103.38 (-3.41%)
Repligen: Q1 Earnings Snapshot

Repligen: Q1 Earnings Snapshot

RGEN : 103.38 (-3.41%)
Repligen Reports First Quarter 2026 Financial Results and Updates Full Year 2026 Financial Guidance

First quarter revenue of $194 million, a year-over-year increase of 15% as reported and 11% organic GAAP EPS increased 50% year-over-year and adjusted EPS increased 23% year-over-year Reiterating...

RGEN : 103.38 (-3.41%)
Repligen's Margin Recovery Narrative Collides With Its Capital Equipment Problem

Barchart Research What to Expect from RGEN Earnings RGEN Generated May 4, 2026 Current Price $118.21 EPS Estimate $$0.38 Consensus Rating Strong Buy Average Move 6.06% Repligen's Margin Recovery Narrative...

RGEN : 103.38 (-3.41%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Repligen Corporation is a leading provider of advanced bioprocessing technologies and solutions used by large biopharmaceutical companies and contract manufacturing organizations for manufacturing biologic drugs, such as monoclonal antibodies (mAbs) and gene therapies. Repligen earns revenues from the...

See More

Key Turning Points

3rd Resistance Point 113.84
2nd Resistance Point 110.79
1st Resistance Point 107.09
Last Price 103.38
1st Support Level 100.33
2nd Support Level 97.28
3rd Support Level 93.58

See More

52-Week High 175.77
Fibonacci 61.8% 147.20
Fibonacci 50% 138.38
Fibonacci 38.2% 129.56
Last Price 103.38
52-Week Low 100.99

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.